FORT WAYNE, Ind. A terminal diagnosis isn’t keeping a veteran from seeing Washington D.C. one last time.
Category: Financial Services
Obamacare and Dodd-Frank Have the Same Fatal Flaw
… subsidize their constituents indirectly through regulation of private companies. The Affordable Care Act governing health insurers was about 1,000 pages, and Dodd-Frank governing most other financial institutions was more than twice that. Both …
Collegium Pharmaceutical Inc (COLL) Shares Bought by Franklin Resources Inc.
Franklin Resources Inc. boosted its position in shares of Collegium Pharmaceutical Inc by 98.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,797,902 shares of the specialty pharmaceutical company’s stock after buying an additional 890,868 shares during the period.
US stocks slip further from record highs as banks decline
U.S. stocks are starting lower for the second time in three days as most parts of the market slip. Banks, which surged last week as interest rates quickly rose, are returning some of their gains.
AbbVie Inc (ABBV) Stake Lowered by Formidable Asset Management LLC
Formidable Asset Management LLC reduced its position in AbbVie Inc by 3.2% during the fourth quarter, Holdings Channel reports. The fund owned 4,112 shares of the company’s stock after selling 134 shares during the period.
TRACON Pharmaceuticals Inc (TCON) to Post Q1 2017 Earnings of ($0.45) …
TRACON Pharmaceuticals Inc – Analysts at Jefferies Group upped their Q1 2017 earnings estimates for shares of TRACON Pharmaceuticals in a research note issued to investors on Wednesday. Jefferies Group analyst B. Abrahams now forecasts that the brokerage will earn per share for the quarter, up from their prior estimate of .
Wedbush Weighs in on DexCom, Inc.’s Q1 2017 Earnings
Investment analysts at Wedbush issued their Q1 2017 earnings estimates for shares of DexCom in a research note issued to investors on Wednesday. Wedbush analyst Levy.
Puma Biotechnology Inc (PBYI) Rating Reiterated by Citigroup Inc.
‘s stock had its “buy” rating reissued by research analysts at Citigroup Inc. in a research report issued on Saturday. They currently have a $88.00 price target on the biopharmaceutical company’s stock.
Perrigo Company plc (PRGO) Rating Reiterated by Canaccord Genuity
… over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug …
Press release distribution, EDGAR filing, XBRL, regulatory filings
The links … )–Blackstone announced today that it has filed with the U.S. Securities and Exchange Commission its Annual Report on Form 10-K for the year ended December 31, 201… )–HFF has closed the $227 million sale of and arranged $175 million in financing for Tysons Metro Center, a four-building, Class A office portfolio totaling 763,965 squar… )–Rayonier Inc. announced today that the company’s board of directors has declared a first quarter cash dividend of $0.25 per common share. The dividen… )–John Gerspach, Chief Financial Officer of Citigroup, will present at the RBC Capital Markets 2017 Financial Institutions Conference on Tuesday, March 7, 2017.
Massmutual Trust Co. FSB Adv Buys New Stake in Nevro Corp
Massmutual Trust Co. FSB ADV bought a new position in Nevro Corp during the fourth quarter, Holdings Channel reports.
2/12/2017
… to repeal – a promise that is proving to be more complicated to keep than he had expected. Mr. Cohn is working with a health care specialist and consulting with House Republicans: Speaker Paul D. Ryan; Kevin McCarthy, the majority leader; and Jeb …
2/12/2017
… to repeal – a promise that is proving to be more complicated to keep than he had expected. Mr. Cohn is working with a health care specialist and consulting with House Republicans: Speaker Paul D. Ryan; Kevin McCarthy, the majority leader; and Jeb …
A.M. Best Removes from Under Review and Takes Various Credit Rating…
A.M. Best Removes from Under Review and Takes Various Credit Rating Actions on Insurance Subsidiaries of Nassau Reinsurance Group Holdings, L.P. A.M. Best Removes from Under Review and Takes Various Credit Rating Actions on Insurance Subsidiaries of Nassau Reinsurance Group Holdings, L.P. A.M. Best has removed from under review with developing implications and affirmed the Financial Strength Rating of B and the Long-Term Issuer Credit Ratings of “bb+” of the key life/health subsidiaries of The Phoenix Companies, Inc. . Additionally, the Long-Term ICR of “b” of Phoenix and its existing Long-Term Issue Credit Ratings have been removed from under review with developing implications and affirmed.
Check Cap LTD (Chek) Coverage Initiated by Analysts at Rodman & Renshaw
The brokerage issued a buy rating and a $6.00 price target on the stock. Separately, Maxim Group set a $6.00 target price on shares of CHECK CAP LTD and gave the company a buy rating in a report on Monday, October 24th.
Brokerages Set Neurocrine Biosciences Inc. (NBIX) Price Target at $66.09
… two lead late-stage clinical programs are Elagolix, a gonadotropin-releasing hormone (GnRH) antagonist for women’s health that is partnered with AbbVie Inc (AbbVie), and NBI-98854 (valbenazine), a vesicular monoamine transporter 2 (VMAT2) inhibitor …
FTSE 100 movers: Burberry shines on update but Pearson tanks
London’s FTSE 100 was up 0.2% to 7,235.79 in afternoon trade, with updates from Burberry and Pearson in focus. Luxury retailer Burberry was the standout gainer after it reported 4% growth in underlying retail sales for the third quarter, boosted by a return to growth for the Asia Pacific region but with the Americas still in decline.
Retirement Weekly: Investments for retirement
… exchange-traded funds focused on distinct sectors of the economy. The consumer discretionary, energy, financials, health care, industrials, information technology, materials, consumer staples and utilities ETFs select investments from Standard & …
Press release distribution, EDGAR filing, XBRL, regulatory filings
… red into a broad-ranging partnership with digital life company iCarbonX to accelerate a deeper understanding of human health and disease.
Press release distribution, EDGAR filing, XBRL, regulatory filings
… red into a broad-ranging partnership with digital life company iCarbonX to accelerate a deeper understanding of human health and disease.
Exelixis Inc. (EXEL) Stake Raised by Swiss National Bank
Swiss National Bank increased its position in shares of Exelixis Inc. by 1.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The fund owned 367,300 shares of the biotechnology company’s stock after buying an additional 5,600 shares during the period.
Press release distribution, EDGAR filing, XBRL, regulatory filings
… accomplishments of seven Key … )–The Assistance Fund helps primary biliary cholangitis patients with copays, health insurance premiums & incidental medical expenses through its Primary Biliary Chola… )–DigitalTrends.com,the premier site for …
Lincoln Financial Group’s Nancy Smith Honored by Philadelphia’s…
Lincoln Financial Group announced today that Nancy Smith, vice president, senior counsel and assistant corporate secretary, has been honored by the Homeless Advocacy Project for her volunteer work facilitating and contributing to pro bono legal clinics. “The legal clinics sponsored by HAP play an instrumental role in transforming the lives of homeless individuals and families,” said Kirkland Hicks, executive vice president and general counsel for Lincoln Financial.
Health care stocks skid, keeping Dow short of 20,000 mark
U.S. stock indexes are slightly lower Wednesday as health care companies continue to struggle. The price of natural gas is surging as winter begins, and that’s giving energy companies a lift.
A sluggish open for stocks keeps Dow short of 20,000 mark
U.S. stock indexes are slightly lower Wednesday morning as health care companies and banks slip. Household goods makers, including companies that sell snacks and drinks, are bouncing back from losses a day ago.
TIMELINE: The tumultuous 155-year history of oil prices
Most recently, after two years of depressed prices, OPEC agreed to curtail output by 1.2 million barrels per day at its meeting in Vienna in late November in an attempt to end the global supply glut. Several non-OPEC producers including Russia tagged along in December, agreeing to reduce output by about 560,000 bpd .
Richmond fuel additive maker Afton to acquire Mexico-based firm for $182.5M
Afton Chemical Corp., a global leader in the lubricant and fuel additive market and a wholly owned subsidiary of Richmond-based NewMarket Corp., announced Monday an agreement to acquire Aditivos Mexicanos, S.A. de C.V. for $182.5 million. Click here to create a free user account to enter a calendar events, update your business directory listing or comment on an obituary.
Richmond fuel additive maker Afton to acquire Mexico-based firm for $182.5M
Afton Chemical Corp., a global leader in the lubricant and fuel additive market and a wholly owned subsidiary of Richmond-based NewMarket Corp., announced Monday an agreement to acquire Aditivos Mexicanos, S.A. de C.V. for $182.5 million. Click here to create a free user account to enter a calendar events, update your business directory listing or comment on an obituary.
Largest public pension system to sell all tobacco stocks
The California Public Employees’ Retirement System decided Monday to sell its last $550 million worth of tobacco-related investments nearly two decades after trading away the bulk of them. In a 9-3 vote, the CalPERS investment committee disregarded the advice from its own financial advisers who recommended reversing a sell-off approved in 2000, which has cost the system more than $3 billion in lost earnings.
The nation’s largest public pension system is giving up tobacco.
The California Public Employees’ Retirement System decided Monday to sell off its last $550 million worth of tobacco-related investments nearly two decades after trading away the bulk of them. In a 9-3 vote, the CalPERS investment committee disregarded the advice from its own financial advisers who recommended reversing a sell-off approved in 2000, which has cost the system more than $3 billion in lost earnings.